Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Capital Expenditures (2022 - 2025)

Medinotec filings provide 4 years of Capital Expenditures readings, the most recent being -$179372.0 for Q1 2025.

  • On a quarterly basis, Capital Expenditures fell 12675.78% to -$179372.0 in Q1 2025 year-over-year; TTM through Feb 2025 was -$89013.0, a 220.34% decrease, with the full-year FY2025 number at -$89013.0, down 3847.36% from a year prior.
  • Capital Expenditures hit -$179372.0 in Q1 2025 for Medinotec, down from $72626.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $86602.0 in Q4 2022 to a low of -$179372.0 in Q1 2025.
  • Median Capital Expenditures over the past 4 years was -$3910.0 (2023), compared with a mean of -$12569.6.
  • Biggest five-year swings in Capital Expenditures: surged 98.05% in 2023 and later crashed 12675.78% in 2025.
  • Medinotec's Capital Expenditures stood at $86602.0 in 2022, then plummeted by 102.04% to -$1765.0 in 2023, then soared by 4214.79% to $72626.0 in 2024, then tumbled by 346.98% to -$179372.0 in 2025.
  • The last three reported values for Capital Expenditures were -$179372.0 (Q1 2025), $72626.0 (Q4 2024), and $23788.0 (Q3 2024) per Business Quant data.